Back to Search
Start Over
Immune-related lichenoid mucocutaneous erosions during anti-PD-1 immunotherapy in metastatic renal cell carcinoma - A case report
- Source :
- Urology Case Reports, Vol 23, Iss , Pp 1-2 (2019)
- Publication Year :
- 2019
- Publisher :
- Elsevier, 2019.
-
Abstract
- Nivolumab belongs to the standard treatment options in metastatic renal cell carcinoma. Despite promising responses, a new spectrum of “immune-related” adverse effects has to be managed in daily clinical practice. A 74-year-old patient was treated with nivolumab in fourth-line. After 18 cycles, treatment was stopped due to severe adverse mucocutaneous reactions confirming a lichen ruber pemphigoides. CT scans during treatment discontinuation show stable disease since more than 14 months. Immunotherapy can cause mucocutaneous immune-mediated adverse reactions. The time of onset to cutaneous adverse effects is variable. Early recognition and treatment are essential in mitigating the severity of those adverse events. Keywords: Renal cell cancer, Nivolumab, Lichen ruber, Side effects, Cutaneous adverse event
- Subjects :
- Diseases of the genitourinary system. Urology
RC870-923
Subjects
Details
- Language :
- English
- ISSN :
- 22144420
- Volume :
- 23
- Issue :
- 1-2
- Database :
- Directory of Open Access Journals
- Journal :
- Urology Case Reports
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.139489dff70349a8a74f2e0f84b27c98
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.eucr.2018.11.008